marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Pfizer Financial Statements 2011-2024 | PFE
Annual Financial Statements Pfizer
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
156 B | 238 B | 261 B | 178 B | 196 B | 232 B | 214 B | 181 B | 179 B | 188 B | 199 B | 194 B | 160 B |
Shares |
5.64 B | 5.61 B | 5.6 B | 5.56 B | 5.57 B | 5.87 B | 5.97 B | 6.09 B | 6.18 B | 6.35 B | 6.81 B | 7.44 B | 7.82 B |
Historical Prices |
27.6 | 42.4 | 46.6 | 32 | 29.1 | 36.3 | 29.4 | 26.6 | 22.3 | 24.9 | 22.5 | 18.6 | 13.8 |
Net Income |
2.12 B | 31.4 B | 22 B | 9.16 B | 16.3 B | 11.2 B | 21.3 B | 7.22 B | 6.96 B | 9.14 B | 22 B | 14.6 B | 10 B |
Revenue |
58.5 B | 100 B | 81.3 B | 41.7 B | 51.8 B | 53.6 B | 52.5 B | 52.8 B | 48.9 B | 49.6 B | 51.6 B | 59 B | 67.4 B |
Cost of Revenue |
25 B | 34.3 B | 30.8 B | 8.48 B | 8.05 B | 8.99 B | 11.2 B | 12.3 B | - | - | 9.59 B | 9.82 B | 12.5 B |
Gross Profit |
- | - | - | - | 41.5 B | 42.4 B | 41.3 B | 40.5 B | 39.2 B | 40 B | 42 B | 47.7 B | 52.3 B |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.21 B | 1.24 B | 1.29 B | 1.45 B | 1.57 B | 1.32 B | 1.27 B | 1.19 B | 1.2 B | 1.36 B | 1.41 B | 1.52 B | 1.68 B |
EBITDA |
6.29 B | 5.06 B | 5.19 B | 4.68 B | 18.5 B | 19.9 B | 18.9 B | 17.8 B | 16.7 B | 17.5 B | 21 B | 23.2 B | 23.8 B |
Operating Expenses |
- | - | - | - | 27.6 B | 27.4 B | 27.2 B | 26.8 B | 26.2 B | 26.5 B | 25.6 B | 29.7 B | 34.2 B |
General and Administrative Expenses |
14.8 B | 13.7 B | 12.7 B | 11.6 B | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Pfizer
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
5.67 B | 5.67 B | 5.66 B | 5.65 B | 5.65 B | 5.63 B | - | 5.61 B | 5.59 B | 5.62 B | - | 5.61 B | 5.6 B | 5.58 B | - | 5.56 B | 5.55 B | 5.54 B | - | 5.54 B | 5.56 B | 5.64 B | - | 5.88 B | 5.87 B | 5.96 B | - | 5.95 B | 5.96 B | 6.01 B | - | 6.07 B | 6.07 B | 6.15 B | - | 6.17 B | 6.16 B | 6.2 B | - | 6.33 B | 6.37 B | 6.39 B | - | 6.58 B | 7.04 B | 7.19 B | - | 7.44 B | 7.48 B | 7.54 B | - | 7.77 B | 7.88 B | 7.98 B |
Net Income |
4.46 B | 41 M | 3.12 B | -2.38 B | 2.33 B | 5.54 B | - | 8.61 B | 9.91 B | 7.86 B | - | 8.15 B | 5.56 B | 4.88 B | - | 1.47 B | 3.49 B | 3.36 B | - | 7.68 B | 5.05 B | 3.88 B | - | 4.11 B | 3.87 B | 3.56 B | - | 2.84 B | 3.07 B | 3.12 B | - | 1.36 B | 2.05 B | 3.04 B | - | 2.13 B | 2.63 B | 2.38 B | - | 2.67 B | 2.91 B | 2.33 B | - | 2.59 B | 14.1 B | 2.75 B | - | 3.21 B | 3.25 B | 1.79 B | - | 3.74 B | 2.61 B | 2.22 B |
Revenue |
17.7 B | 13.3 B | 14.9 B | 13.5 B | 13 B | 18.5 B | - | 22.6 B | 27.7 B | 25.7 B | - | 24 B | 18.9 B | 14.5 B | - | 10.3 B | 9.86 B | 10.1 B | - | 12.7 B | 13.3 B | 13.1 B | - | 13.3 B | 13.5 B | 12.9 B | - | 13.2 B | 12.9 B | - | - | - | - | - | - | - | - | - | - | - | 104 M | 92 M | - | 12.6 B | 102 M | 95 M | - | 13 B | 14 B | 14.9 B | - | 16.6 B | 17 B | 16.5 B |
Cost of Revenue |
5.26 B | 3.3 B | 3.38 B | 9.27 B | 3.24 B | 4.89 B | - | 6.06 B | 8.65 B | 9.98 B | - | 9.93 B | 7 B | 4.16 B | - | 2.01 B | 1.83 B | 1.94 B | - | 2.6 B | 2.58 B | 2.43 B | - | 2.69 B | 2.92 B | 2.56 B | - | 2.84 B | 2.66 B | - | - | - | - | - | - | - | - | - | - | - | - | 2.04 B | - | 2.29 B | 2.24 B | 2.26 B | - | 2.31 B | 2.38 B | 2.74 B | - | 3.41 B | 3.8 B | 3.69 B |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
783 M | 778 M | 790 M | 695 M | 508 M | 318 M | - | 311 M | 293 M | 322 M | - | 325 M | 316 M | 336 M | - | 345 M | 367 M | 390 M | - | 409 M | 389 M | 361 M | - | 310 M | 326 M | 310 M | - | 320 M | 312 M | 309 M | - | 291 M | 292 M | 306 M | - | 278 M | 278 M | 309 M | - | 343 M | 343 M | 321 M | - | 340 M | 356 M | 371 M | - | 381 M | 378 M | 390 M | - | 423 M | 404 M | 458 M |
EBITDA |
- | - | 1.74 B | - | - | 1.49 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.1 B | 1.2 B | 1.77 B | - | 5.55 B | 3.89 B | 2.22 B | - | 6.57 B | 4.35 B | 2.1 B |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
3.24 B | 3.72 B | 3.5 B | 3.28 B | 3.5 B | 3.42 B | - | 3.39 B | 3.05 B | 2.59 B | - | 2.9 B | 2.92 B | 2.78 B | - | 2.66 B | 2.66 B | 2.54 B | - | 3.26 B | 3.51 B | 3.34 B | - | 3.49 B | 3.54 B | 3.41 B | - | 3.5 B | 3.43 B | 3.32 B | - | 3.56 B | 3.47 B | 3.38 B | - | 3.27 B | 3.39 B | 3.1 B | - | 3.56 B | 3.52 B | 3.04 B | - | 3.4 B | 3.59 B | 3.22 B | - | 3.49 B | 3.66 B | 3.97 B | - | 4.46 B | 4.97 B | 4.5 B |
All numbers in USD currency